These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 121980)

  • 1. [In vitro antibacterial activity of a halogenated derivative of D-alanine].
    Viano I; Santiano M; Savoia D
    G Batteriol Virol Immunol; 1979; 72(1-6):134-42. PubMed ID: 121980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of fosfomycin].
    Giola L; Rizzu D; Zanetti S
    G Batteriol Virol Immunol; 1979; 71(1-6):34-40. PubMed ID: 385409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the combined action of phosphonomycin with streptomycin, penicillin G and ampicillin.
    Borowski J; Linda H
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):191-5. PubMed ID: 776120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
    Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
    Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin. I. Antimicrobial action in vitro].
    Carlone NA; Cuffini AM; Cattaneo O
    G Batteriol Virol Immunol; 1977; 70(1-6):100-7. PubMed ID: 614140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological relevance and clinical potential of ampicillin-cloxacillin synergism.
    Barrelet L; Regamey C; Waldvogel FA
    Biomedicine; 1977 May; 26(3):169-75. PubMed ID: 329905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of combined action of beta-lactame and aminoglycoside antibiotics on resistant strains of streptococcus group D.
    Zaremba L; Linda H; Dzierzanowska D
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):853-9. PubMed ID: 261659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergy of ampicillin and chloramphenicol against gram-negative bacteria.
    Kaplan SL; Mason EO
    Pediatr Pharmacol (New York); 1981; 1(4):305-11. PubMed ID: 7346749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of fosfomycin. II. Determination of minimal bactericidal concentration in association with other antibiotics].
    Grassi GG; Ferrara A; Navone A; Peona V; Sala P
    G Ital Chemioter; 1977; 23(2):87-94. PubMed ID: 606614
    [No Abstract]   [Full Text] [Related]  

  • 13. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
    Hamilton-Miller JM
    Microbios; 1992; 71(287):95-103. PubMed ID: 1453987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of growth in vitro of bacteria from the oral cavity using a combination of fosfomycin and ampicillin].
    Pase U; Tafuro A
    G Stomatol Ortognatodonzia; 1984; 3(3):358-60. PubMed ID: 6599001
    [No Abstract]   [Full Text] [Related]  

  • 18. [In-vitro synergism between beta-lactamines. I. Anti-bacterial action of ampicillin-cloxacillin combination on Gram-negative bacteria].
    Denis F; Geslin M; Brisou J
    C R Seances Soc Biol Fil; 1973; 167(12):1939-43. PubMed ID: 4214512
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro evaluation of antibacterial activity of the original oxime type of beta-lactam antibiotics with the 4-aminobenzensulfonamide group].
    Holá V; Adensamová J; Mandel M
    Cesk Farm; 1990 Sep; 39(7):299-301. PubMed ID: 2098201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.